Effect of combined oestrogen-progestogen oral contraceptives, oestrogen, and progestogen on antiplasmin and antithrombin activity.
D000328:Adult; D000991:Antithrombins / Q000032:analysis* / Q000378:metabolism; D001777:Blood Coagulation / Q000187:drug effects*; D001779:Blood Coagulation Factors; D001780:Blood Coagulation Tests; D003276:Contraceptives, Oral / Q000494:pharmacology*; D005040:Ethynodiol Diacetate / Q000494:pharmacology*; D005260:Female; D005341:Fibrinolysin / Q000037:antagonists & inhibitors* / Q000378:metabolism; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D008259:Macroglobulins / Q000032:analysis; D008598:Menstruation; D008656:Mestranol / Q000494:pharmacology*; D010958:Plasminogen / Q000378:metabolism; D013927:Thrombosis / Q000139:chemically induced; D013997:Time Factors
D000991:Antithrombins; D001779:Blood Coagulation Factors; D003276:Contraceptives, Oral; D008259:Macroglobulins; D005040:Ethynodiol Diacetate; D010958:Plasminogen; D008656:Mestranol; D005341:Fibrinolysin